Sort
10,766 grants matching “checkpoint inhibitor”
Parameters that determine cell fate during mitotic arrest
$143,997Charles B Shuster · New Mexico State University Las Cruces · R16 · FY2022 · GM
Parameters that determine cell fate during mitotic arrest
$143,997Charles B Shuster · New Mexico State University Las Cruces · R16 · FY2024 · GM
Parameters that determine cell fate during mitotic arrest
$143,997Charles B Shuster · New Mexico State University Las Cruces · R16 · FY2023 · GM
Improving the therapeutic efficacy of chemoradiation by targeting the DNA damage response
$143,779Leslie Anne Parsels · University Of Michigan At Ann Arbor · R50 · FY2021 · CA
Improving the therapeutic efficacy of chemoradiation by targeting the DNA damage response
$143,779Leslie Anne Parsels · University Of Michigan At Ann Arbor · R50 · FY2023 · CA
Improving the therapeutic efficacy of chemoradiation by targeting the DNA damage response
$143,779Leslie Anne Parsels · University Of Michigan At Ann Arbor · R50 · FY2022 · CA
Improving the therapeutic efficacy of chemoradiation by targeting the DNA damage response
$143,779Leslie Anne Parsels · University Of Michigan At Ann Arbor · R50 · FY2020 · CA
Improving the therapeutic efficacy of chemoradiation by targeting the DNA damage response
$143,779Leslie Anne Parsels · University Of Michigan At Ann Arbor · R50 · FY2024 · CA
Translation Initiation Inhibitor for Cancer Therapy
$143,196Moira Sauane · Herbert H. Lehman College · R16 · FY2025 · GM
Role of human endogenous retroviruses in tumor immunity of ovarian carcinoma
$143,189Katherine B Chiappinelli · George Washington University · R21 · FY2019 · CA
Signaling Pathways in Neuronal Cells
$142,947Marsha R Rosner · University Of Chicago · R01 · FY2013 · GM
Defining immune footprint in tumor microenvironment following high salt synergized inflammatory cytokine mediated breast cancer progression
$142,763Venkataswarup Tiriveedhi · Tennessee State University · U54 · FY2017 · CA
Translation Initiation Inhibitor for Cancer Therapy
$142,666Moira Sauane · Herbert H. Lehman College · R16 · FY2024 · GM
Augmenting cancer checkpoint immunotherapies via microbially-derived metabolites
$142,625Matthew Everett Griffin · University Of California-Irvine · K22 · FY2024 · CA
Augmenting cancer checkpoint immunotherapies via microbially-derived metabolites
$142,625Matthew Everett Griffin · University Of California-Irvine · K22 · FY2025 · CA
Targeting APOBEC3A-expressing cancer cells with ATR inhibitors
$142,560Remi Buisson · Massachusetts General Hospital · K99 · FY2017 · CA
Translation Initiation Inhibitor for Cancer Therapy
$142,143Moira Sauane · Herbert H. Lehman College · R16 · FY2023 · GM
Targeting APOBEC3A-expressing cancer cells with ATR inhibitors
$142,027Remi Buisson · Massachusetts General Hospital · K99 · FY2018 · CA
Role of T Regulatory Cell Suppression in Autoimmunity and Cancer
$141,879Joost J Oppenheim · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA
Translation Initiation Inhibitor for Cancer Therapy
$141,632Moira Sauane · Herbert H. Lehman College · R16 · FY2022 · GM
Airway Immune Response in Critically Ill Children-Precision Medicine in Children At Risk for Acute Respiratory Distress Syndrome
$141,399Jocelyn Rebecca Grunwell · Emory University · K23 · FY2024 · HL
The paradoxical roles of beta hydroxy butyrate in the liver pro-metastatic niche
$140,891Shelly Chi-Loo Lu · Cedars-Sinai Medical Center · P01 · FY2023 · CA
Developmental Therapeutics
$140,755Dustin A Deming · University Of Wisconsin-Madison · P30 · FY2025 · CA
Developmental Therapeutics
$140,755Dustin A Deming · University Of Wisconsin-Madison · P30 · FY2023 · CA
Developmental Therapeutics
$140,755Dustin A Deming · University Of Wisconsin-Madison · P30 · FY2024 · CA